Trial Profile
Ramelteon for Insomnia Comorbid With Asthma.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 May 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 30 Apr 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 25 Apr 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 28 Jun 2012 Primary endpoint identified as insomnia severity index as reported by ClinicalTrials.gov.